By Madona Azar | The Conversation Liver disease is frighteningly common worldwide. Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a buildup of fat in the liver. Formerly known as nonalcoholic fatty liver disease, this condition affects 1 in 4 people worldwide. Among those with type 2 diabetes, insulin […]
By Lauryn Stafford and Liane Ong The big idea The number of people living with diabetes worldwide is on pace to more than double in the next three decades, for a total of 1.3 billion people by 2050. That is one of the key findings from our study on the global burden of diabetes recently published in […]
By Richard Johnson, The Conversation Scientific studies and media coverage are rife with warnings on how sugar, carbohydrates, saturated fat and lack of exercise contribute to obesity. And tens of millions of Americans are still overweight or obese in large part because of the classic Western diet and lifestyle. As an educator, researcher and professor […]
By Duane Mellor and Adrian Brown, The Conversation Until recently, type 2 diabetes has mainly been managed by controlling risk factors – such as high blood pressure, cholesterol and blood sugar (glucose) levels – usually by prescribing drugs. But this approach doesn’t address the underlying causes of type 2 diabetes – such as problems with […]
